Skip to main content
. 2017 Oct 7;8(55):94210–94222. doi: 10.18632/oncotarget.21618

Figure 5. Antitumor activity of ROR1-cFab in ovarian cancer cells.

Figure 5

(A) Wound healing assay. Tumor cells were grown and treated with 40 μg/mL of ROR1-cFab for up to 48 h and then subjected to wound healing assay. (B) Transwell migration assay. Tumor cells were grown and treated with 40 μg/mL of ROR1-cFab for up to 24h and then subjected to Transwell migration assay. Data are shown as mean ± SD (n = 3, NS, not significant, *p < 0.05, **p < 0.01, and ***p < 0.001 compared with the control).